[go: up one dir, main page]

Kim et al., 2001 - Google Patents

Effects of folate supplementation on two provisional molecular markers of colon cancer: a prospective, randomized trial

Kim et al., 2001

View PDF
Document ID
5043126052156605109
Author
Kim Y
Baik H
Fawaz K
Knox T
Lee Y
Norton R
Libby E
Mason J
Publication year
Publication venue
Official journal of the American College of Gastroenterology| ACG

External Links

Snippet

OBJECTIVES: Dietary folate intake is inversely associated with the risk of colorectal cancer. This study investigated the effect of folate supplementation on genomic DNA methylation and DNA strand breaks in exons 5–8 of the p53 gene of the colonic mucosa, two provisional …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)

Similar Documents

Publication Publication Date Title
Kim et al. Effects of folate supplementation on two provisional molecular markers of colon cancer: a prospective, randomized trial
Fenech et al. Folate, vitamin B12, homocysteine status and chromosome damage rate in lymphocytes of older men.
Kim et al. Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats.
Song et al. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/− Msh2−/− mice
Kim et al. Effects of dietary folate on DNA strand breaks within mutation-prone exons of the p53 gene in rat colon
Jacobs et al. Diet, gender, and colorectal neoplasia
Fuchs et al. The influence of folate and multivitamin use on the familial risk of colon cancer in women
Young-In et al. Colonic mucosal concentrations of folate correlate well with blood measurements of folate status in persons with colorectal polyps
Kim et al. DNA hypomethylation in inflammatory arthritis: reversal with methotrexate
Martínez et al. Folate and colorectal neoplasia: relation between plasma and dietary markers of folate and adenoma recurrence
Tamura et al. Homocysteine, folate, vitamin B-12 and vitamin B-6 in patients receiving antiepileptic drug monotherapy
Zhou et al. Estrogen status alters tissue distribution and metabolism of selenium in female rats
US11026917B2 (en) Antioxidative stress compositions, methods of preparing and uses thereof
van den Donk et al. Folic acid and vitamin B-12 supplementation does not favorably influence uracil incorporation and promoter methylation in rectal mucosa DNA of subjects with previous colorectal adenomas
Cravo et al. Microsatellite instability in non-neoplastic mucosa of patients with ulcerative colitis: effect of folate supplementation
Guerreiro et al. Risk of colorectal cancer associated with the C677T polymorphism in 5, 10-methylenetetrahydrofolate reductase in Portuguese patients depends on the intake of methyl-donor nutrients
Kotsopoulos et al. Folate and breast cancer: what about high-risk women?
Ingles et al. Plasma tocopherol and prevalence of colorectal adenomas in a multiethnic population
de OG Mendonça et al. Effects of an oxalate load on urinary oxalate excretion in calcium stone formers
Longo et al. Nicotinamide riboside and dietary restriction effects on gut microbiota and liver inflammatory and morphologic markers in cafeteria diet–induced obesity in rats
Kelley et al. Safety and efficacy of weekly oral oltipraz in chronic smokers
Powers et al. Responses of biomarkers of folate and riboflavin status to folate and riboflavin supplementation in healthy and colorectal polyp patients (the FAB2 Study)
Wacker et al. Effect of enzyme-resistant starch on formation of 1, N 2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal and cell proliferation in the colonic mucosa of healthy volunteers
Friedrich et al. Serum miRNA-122 is an independent biomarker of survival in patients with primary sclerosing cholangitis.
Rayman et al. Selenium in cancer prevention